Discontinued — last reported Q2 '22
Otis Worldwide Short-Term Borrowings increased by 80.7% to $244.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 510.0%, from $40.00M to $244.00M. Over 5 years (FY 2020 to FY 2025), Short-Term Borrowings shows a downward trend with a -28.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $343.00M | $38.00M | $24.00M | $51.00M | $81.00M | $103.00M | $139.00M | $107.00M | $200.00M | $54.00M | $32.00M | $35.00M | $356.00M | $367.00M | $51.00M | $40.00M | $528.00M | $348.00M | $135.00M | $244.00M |
| QoQ Change | — | -88.9% | -36.8% | +112.5% | +58.8% | +27.2% | +35.0% | -23.0% | +86.9% | -73.0% | -40.7% | +9.4% | +917.1% | +3.1% | -86.1% | -21.6% | >999% | -34.1% | -61.2% | +80.7% |
| YoY Change | — | — | — | — | -76.4% | +171.1% | +479.2% | +109.8% | +146.9% | -47.6% | -77.0% | -67.3% | +78.0% | +579.6% | +59.4% | +14.3% | +48.3% | -5.2% | +164.7% | +510.0% |